Selegiline tablets

Company
Teva Pharmaceutical

Approval Status
Approved January 1997

Treatment for
Parkinson’s disease

Areas
Neurology & Nervous System

Selegiline has been approved for the treatment of Parkinson's disease. Selegiline is a generic equivalent of Somerset’s Eldepryl tablets, a drug for the treatment of Parkinson’s disease. Other generic versions of this product have been introduced over the last several months.

Selegiline_tablets Drug Information

The Selegiline_tablets drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top